Transaction #3990 · Form 4 · 0001520262-25-000010
Alkermes plc. · Exercise / conversion · Ordinary Shares
Alkermes plc. · Transacted November 3, 2025 · Filed November 3, 2025
What does this filing report?
An SEC Form 4 filing for Alkermes plc. records an exercise / conversion involving Ordinary Shares on November 3, 2025. The reported quantity was 5,000. The filing date is November 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Alkermes plc.
- Company CIK
- 0001520262
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,000
- Reported price
- 19.34
- Reference value
- 96,700
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 78,740
- Ownership description
- Not reported
- SEC acceptance time
- Nov 3, 2025, 4:37 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hopkinson Craig C. ↗
EVP R&D, Chief Medical Officer
CIK 0001730048
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- F2
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
- F3
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
- F4
- These options are fully vested in accordance with their terms.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.